NeuroPace Inc (NASDAQ:NPCE) price on Thursday, July 03, fall -0.29% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $10.39.
A look at the stock’s price movement, the close in the last trading session was $10.42, moving within a range at $10.24 and $10.635. The beta value (5-Year monthly) was 2.042. Turning to its 52-week performance, $18.98 and $5.45 were the 52-week high and 52-week low respectively. Overall, NPCE moved -23.26% over the past month.
NeuroPace Inc’s market cap currently stands at around $340.78 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-13.
Turning to the stock’s technical picture we see that short term indicators suggest on average that NPCE is a 50% Sell. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 2 analyst(s) rate the stock as a Hold, 2 recommend NPCE as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
NPCE’s current price about -7.76% and -18.16% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.54, while 7-day volatility ratio is 6.96% and 6.58% in the 30-day chart. Further, NeuroPace Inc (NPCE) has a beta value of 1.94. Analysts have given the company’s stock an average 52-week price target of $13, forecast between a low of $5.5 and high of $20. Looking at the price targets, the low is 47.06% off current price level while to achieve the yearly target high, price needs to move -92.49%. Nonetheless, investors will most likely welcome a -25.12% jump to $13 which is the analysts’ median price.
If we refocus on NeuroPace Inc (NASDAQ:NPCE), historical trading data shows that trading volumes averaged 0.54 over the past 10 days and 352.74K over the past 3 months. The company’s latest data on shares outstanding shows there are 32.75 million shares.
The 30.79% of NeuroPace Inc’s shares are in the hands of company insiders while institutional holders own 61.13% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.36 million on 2025-06-13, giving us a short ratio of 0.71. The data shows that as of 2025-06-13 short interest in NeuroPace Inc (NPCE) stood at 184.0 of shares outstanding, with shares short falling to 0.4 million registered in 2025-05-15. Current price change has pushed the stock 41.94% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NPCE stock continues to rise going into the next quarter.
